RENOVION is a clinical stage pharmaceutical company that provides nebulized therapy.
RENOVION has raised $15.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2023.
RENOVION's investors include Texas HALO Fund, Whiterock Capital.
RENOVION is headquartered in Chapel Hill, United States.
RENOVION is a clinical stage pharmaceutical company that provides nebulized therapy.
RENOVION is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"RENOVION — Funding & Investors." VCBacked, March 28, 2023, https://www.vcbacked.co/company/renovion. Accessed August 14, 2026.
VCBacked. (2023). RENOVION — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/renovion
{{cite web |title=RENOVION — Funding & Investors |url=https://www.vcbacked.co/company/renovion |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated